Genesis IBRC India Achieves 52-Week High Amidst Market Strength and Erratic Trading
Genesis IBRC India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs. 41.93 on September 8, 2025. The stock has shown strong performance, outperforming its sector and trading above key moving averages, despite some erratic trading activity in recent weeks.
Genesis IBRC India, a microcap player in the Pharmaceuticals & Biotechnology sector, has made headlines today as its stock price reached a new 52-week high of Rs. 41.93. This milestone was achieved on September 8, 2025, marking a significant moment for the company. The stock has shown strong performance, outperforming its sector by 5.52% today and recording a consecutive gain over the last two days, with a total increase of 10.23% during this period.Trading activity has been somewhat erratic, with the stock not trading on four out of the last 20 days. However, it opened with a notable gain of 4.98% today and has maintained its price at Rs. 41.93 throughout the trading session. Additionally, Genesis IBRC India is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its recent performance.
In the broader market context, the Sensex opened higher today at 80,904.40, reflecting a gain of 193.64 points (0.24%), while the BSE Mid Cap index is also showing strength with a gain of 0.34%. Over the past year, Genesis IBRC India has maintained a performance of 0.00%, contrasting with the Sensex's decline of 0.47%. The stock's 52-week low stands at Rs. 15.1, highlighting its recent upward trajectory.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
